Phase 4 Osteoporosis Trial, Recruiting NCT06643780 Sponsor: Prince of Wales Hospital, Shatin, Hong Kong Condition: Osteoporosis
Back to Osteoporosis

Phase 4 Osteoporosis Trial, Recruiting

NCT06643780
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 65 years or older, of any gender
  • People who have been diagnosed with both sarcopenia (low muscle mass and either low grip strength or poor physical performance, measured using specific tests and a body scan) and osteoporosis (low bone density, with a specific scan score of -2.5 or below), a combined condition called osteosarcopenia
  • People who are willing and able to attend follow-up visits and take part in all parts of the study as required

Who may not be able to join:

  • People who have had a bone fracture within the last 3 months
  • People who have previously taken medication for osteoporosis
  • People with a condition or who take medication that is known to affect bone or muscle health
  • People who are unable to move around independently and are confined to a chair or bed
  • People who are unable to give informed consent to participate
  • People for whom the study medications (Denosumab or Zoledronic Acid) are medically unsuitable
  • People with an active cancer or a condition known to cause significant muscle and weight loss
  • People with severely reduced kidney function (confirm with trial site)
  • People with moderate to severe liver disease (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 852 3505 1654

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Prince of Wales Hospital, Shatin, Hong Kong
Registry
ClinicalTrials.gov
Start date
9 April 2024
Est. completion
1 April 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

6-metre walk; 5-time chair stand test; Appendicular skeletal muscle mass (ASM); Handgrip strength; Quadriceps muscle strength; Balancing ability; Balancing ability; Balancing ability; Balancing ability; Balancing ability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov